Apontis Pharma AG

    Apontis Pharma AG

    XXETR:APPH
    11.00
    EUR
    0.00
    (0.00%)
    Apontis Pharma AG
    XETR:APPH
    (Deutsche Borse Xetra)

    Recent

    price

    11.00

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2018
    2019
    2020
    2021
    2022
    2023
    2024
    EUR
    - -
    4.71
    4.62
    6.02
    6.56
    4.35
    5.82
    Revenue per Share
    - -
    -0.28
    -0.14
    -0.09
    0.32
    -1.33
    0.09
    Basic EPS, GAAP
    - -
    -0.15
    0.08
    0.21
    0.91
    -1.87
    -0.63
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    -0.25
    -0.39
    0.52
    0.84
    -0.49
    -0.41
    Book Value per Share
    - -
    -1.3
    -1.33
    3.06
    2.99
    1.5
    1.6
    Tangible Book Value per Share
    - -
    9
    9
    9
    9
    9
    8
    Basic Weighted Avg Shares
    - -
    40
    39
    51
    56
    37
    48
    Sales/Revenue/Turnover
    - -
    -5.6
    -1.56
    3.26
    6.84
    -40.9
    2.61
    Operating Margin (%)
    - -
    1
    2
    2
    2
    2
    2
    Depreciation Expense
    - -
    -2
    -1
    -1
    3
    -11
    1
    Net Income, GAAP
    - -
    - -
    - -
    399.55
    29.76
    - -
    34.62
    Effective Tax Rate (%)
    - -
    -5.98
    -3.01
    -1.46
    4.82
    -30.58
    1.55
    Profit Margin (%)
    1
    -3
    -5
    35
    38
    25
    19
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    7
    5
    3
    41
    42
    30
    31
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    -344.04
    47.11
    - -
    -109.1
    Return on Capital (%)
    - -
    - -
    - -
    - -
    46.52
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    205.84%
    2.49%
    Free Cash Flow
    - -
    -9.08%
    -66.95%
    Net Income, GAAP
    - -
    -235.08%
    -106.67%
    Sales/Revenue/Turnover
    - -
    6.95%
    31.12%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    37
    2024
    - -
    - -
    - -
    - -
    48
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    -1.33
    2024
    - -
    - -
    - -
    - -
    0.09
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business